Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ 42,022,594	$ (1,569,399)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Accretion of investments	(456,933)	(149,951)
Realized investment gains, net	(2,120,242)	(8,973,842)
Change in fair value of equity securities	(51,172,076)	7,209,399
Amortization of cost of insurance acquired	476,861	495,943
Provision for deferred income taxes	10,090,907	(446,037)
Depreciation and depletion	1,408,204	447,698
Stock-based compensation	349,312	674,390
Charges for mortality and administration of universal life and annuity products	(4,115,148)	(4,288,294)
Interest credited to account balances	2,682,616	2,741,851
Change in accrued investment income	518,533	133,627
Change in reinsurance receivables	422,464	865,679
Change in policy liabilities and accruals	(2,126,806)	(3,464,745)
Change in income taxes receivable (payable)	752,633	(6,611,271)
Change in other assets and liabilities, net	714,891	3,210,465
Net cash used in operating activities	(552,190)	(9,724,487)
Proceeds from investments sold and matured:
Fixed maturities available for sale	5,000,000	4,058,333
Equity securities	10,408,667	6,861,942
Trading securities	102,699	0
Mortgage loans	2,402,495	17,601,131
Notes receivable	1,103,360	4,650,509
Real estate	3,098,290	15,533,712
Policy loans	864,973	1,106,310
Short-term investments	22,500,000	9,740,815
Total proceeds from investments sold and matured	45,480,484	59,552,752
Cost of investments acquired:
Equity securities	(10,882,905)	(7,874,161)
Trading securities	(102,699)	0
Mortgage loans	(5,301,867)	(2,050,124)
Notes receivable	(800,000)	(3,579,241)
Real estate	(11,603,519)	(4,115,151)
Policy loans	(658,774)	(699,167)
Short-term investments	(950,925)	(29,300,034)
Total cost of investments acquired	(30,300,689)	(47,617,878)
Net cash provided by investing activities	15,179,795	11,934,874
Cash flows from financing activities:
Policyholder contract deposits	3,056,728	3,144,884
Policyholder contract withdrawals	(3,534,666)	(3,315,173)
Proceeds from notes payable/line of credit	0	2,500,000
Payments of principal on notes payable/line of credit	(19,000,000)	(21,500,000)
Purchase of treasury stock	(326,731)	(765,048)
Net cash used in financing activities	(19,804,669)	(19,935,337)
Net decrease in cash and cash equivalents	(5,177,064)	(17,724,950)
Cash and cash equivalents at beginning of period	41,185,196	45,290,385
Cash and cash equivalents at end of period	$ 36,008,132	$ 27,565,435